BF
SLS icon

Brooklyn FI’s SELLAS Life Sciences SLS Stock Holding History

Brooklyn FI’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,240
Closed -$16.5K – 84
2025
Q3 		$16.5K Hold
10,240
– – ﹤0.01% 79
2025
Q2 		$22.4K Buy
10,240
+100
+1% +$153 0.01% 77
2025
Q1 		$11K Buy
+10,140
New +$12K ﹤0.01% 66
2024
Q2 		– Sell
-11,178
Closed -$11.3K – 61
2024
Q1 		$11.3K Buy
+11,178
New +$9.39K ﹤0.01% 55

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brooklyn FI's SLS Position: Q4 2025 in Review

Brooklyn FI sold out of SELLAS Life Sciences (SLS) in Q4 2025, closing a stake of 10,240 shares — an estimated $16.5K sold.

Brooklyn FI first reported a position in SLS in Q1 2024 and held it in 4 quarters. The position peaked at $22.4K in Q2 2025. 112 funds tracked by Wall St. Rank hold SLS as of Q4 2025.

  • Brooklyn FI reported no remaining SELLAS Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Brooklyn FI sold 10,240 SELLAS Life Sciences shares in Q4 2025, an estimated $16.5K.
  • Brooklyn FI first reported a position in SELLAS Life Sciences in Q1 2024 and held it in 4 quarters.
  • Brooklyn FI's SELLAS Life Sciences position peaked at $22.4K in Q2 2025.
  • 112 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2025.

Based on Brooklyn FI's 13F filing for Q4 2025, filed 21 Jan 2026.